Merit Medical Systems Inc... (MMSI)
103.96
0.69 (0.67%)
At close: Mar 28, 2025, 3:59 PM
105.62
1.60%
After-hours: Mar 28, 2025, 06:36 PM EDT
Merit Medical Systems Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular Revenue | 322.86M | 327.81M | 313.37M | 311.27M | 287.98M | 285.67M | 278.95M | 286.67M | 266.94M | 270.23M |
| Cardiovascular Revenue Growth | -1.51% | +4.61% | +0.67% | +8.09% | +0.81% | +2.41% | -2.69% | +7.39% | -1.22% | n/a |
| Endoscopy Revenue | 16.99M | 10.19M | 10.13M | 8.78M | 9.59M | 7.75M | 8.23M | 8.31M | 8.48M | 8.27M |
| Endoscopy Revenue Growth | +66.76% | +0.53% | +15.41% | -8.43% | +23.79% | -5.84% | -0.96% | -2.04% | +2.56% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|
| China Revenue | 149.3M | 138.2M |
| China Revenue Growth | +8.03% | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 99.64M | 94.58M | 94.43M | 80.81M | 86.85M | 100.93M | 90.14M | 83.24M | 89.78M | 85.49M | 84.02M | 76.63M | 86.47M | 91.56M | 81.02M | 79.93M | 72.22M | 66.77M | 78.81M | 82.09M | 86.94M | 79.98M | 78.27M | 75.63M | 66.38M | 69.21M | 64.91M | 59.24M | 54.72M | 57.41M | 57.77M | 45.84M | 53.2M | 43.65M | 41.7M | 40.94M | 39.2M | 39.32M | 36.88M |
| Selling, General, and Administrative Revenue Growth | +5.35% | +0.17% | +16.86% | -6.96% | -13.94% | +11.96% | +8.29% | -7.28% | +5.02% | +1.75% | +9.64% | -11.38% | -5.56% | +13.01% | +1.36% | +10.69% | +8.16% | -15.28% | -4.00% | -5.57% | +8.70% | +2.18% | +3.49% | +13.93% | -4.09% | +6.63% | +9.58% | +8.27% | -4.69% | -0.63% | +26.03% | -13.83% | +21.87% | +4.67% | +1.86% | +4.44% | -0.31% | +6.60% | n/a |
| Research and Development Revenue | 20.53M | 20.26M | 21.48M | 21.64M | 19.65M | 20.13M | 21.31M | 20.44M | 19.22M | 18.47M | 17.39M | 20.41M | 16.97M | 17.59M | 16.27M | 15.13M | 13.51M | 14.03M | 14.87M | 16.25M | 16.99M | 16.33M | 16.04M | 15.37M | 14.53M | 15.2M | 14.32M | 12.73M | 12.84M | 13.31M | 12.53M | 11.79M | 11.42M | 11.53M | 10.59M | 11.42M | 10.52M | 9.2M | 9.67M |
| Research and Development Revenue Growth | +1.30% | -5.67% | -0.73% | +10.14% | -2.40% | -5.56% | +4.30% | +6.32% | +4.09% | +6.21% | -14.79% | +20.22% | -3.52% | +8.10% | +7.54% | +12.05% | -3.71% | -5.69% | -8.50% | -4.32% | +4.01% | +1.80% | +4.39% | +5.80% | -4.42% | +6.11% | +12.53% | -0.86% | -3.57% | +6.29% | +6.22% | +3.22% | -0.91% | +8.89% | -7.29% | +8.62% | +14.27% | -4.86% | n/a |